Leading Chinese Stem Cell Therapy Provider Expands Capacity Ahead of Schedule TAIZHOU, China, May 11 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the world’s leading biotechnology companies focusing on…
Leading Chinese Stem Cell Therapy Provider Awarded Three ISO9001 Certifications for Stem Cell Technology Quality Management System TAIZHOU, China, April 2 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the…
TAIZHOU, Jiangsu, China, January 6 – The Jiangsu Government’s Science and Technology Department has announced a $1.8 million grant – the Jiangsu Technological Achievements Transformational Grant – to support the…
Beike CSO Speaks at IPA Diabetic Foot Care Conference, India
NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ — Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com ), spoke at a conference on High-Risk Diabetic…
Taizhou, Jiangsu, China, 7 April 2009 – Jiangsu government’s China Medical City (CMC) and Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com) broke ground on the 20,000 square-meter Stem Cell Regenerative Medicine…
Stem Cell Leader Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell
Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established…